This inventor holds 1 USPTO granted patent. Top assignees: Beth Israel Deaconess Medical Center, Inc., Harvard College. Active years: 2021.
Company Filing History:
1 out of 536 
1 out of 3,071 
Years Active: 2021
Title: Mark M Yore: Innovator in Insulin Sensitivity
Introduction
Mark M Yore is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of medical science, particularly in the area of insulin sensitivity. His innovative work has the potential to impact the treatment of various metabolic disorders.
Latest Patents
Mark M Yore holds a patent for "Lipids that increase insulin sensitivity and methods of using the same." This invention introduces fatty acyl hydroxy fatty acid (FAHFA), a novel class of estolide-related molecules. The patent outlines diagnostic and treatment methods for a variety of disorders, including diabetes-related disorders, Metabolic Syndrome, polycystic ovarian syndrome, cancer, and inflammatory disorders. Additionally, it describes methods for screening compounds that can modulate FAHFA levels and their biological effects.
Career Highlights
Throughout his career, Mark M Yore has worked with prestigious institutions such as Beth Israel Deaconess Medical Center and Harvard College. His experience in these organizations has allowed him to collaborate with leading experts in the field.
Collaborations
Some of his notable coworkers include Barbara B Kahn and Mark A Herman. Their collective expertise has contributed to advancements in medical research and innovation.
Conclusion
Mark M Yore's contributions to the field of insulin sensitivity and metabolic disorders highlight his role as an influential inventor. His work continues to pave the way for new treatment methods and diagnostic tools.